These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Isoniazid and Huntington's chorea. Roccatagliata G; Albano C N Engl J Med; 1978 Feb; 298(8):457. PubMed ID: 146161 [No Abstract] [Full Text] [Related]
5. Quantitative evaluation of functional capacity during isoniazid therapy in Huntington's disease. Stober T; Schimrigk K; Holzer G; Ziegler B J Neurol; 1983; 229(4):237-45. PubMed ID: 6192225 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Huntington's chorea with isoniazid. Perry TL; MacLeod PM; Hansen S N Engl J Med; 1977 Oct; 297(15):840. PubMed ID: 142923 [No Abstract] [Full Text] [Related]
7. Isoniazid and Huntington's chorea. Perry TL N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007 [No Abstract] [Full Text] [Related]
8. A double-blind clinical trial of isoniazid in Huntington disease. Perry TL; Wright JM; Hansen S; Thomas SM; Allan BM; Baird PA; Diewold PA Neurology; 1982 Apr; 32(4):354-8. PubMed ID: 6460947 [TBL] [Abstract][Full Text] [Related]
9. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease. Manyam NV; Hare TA; Katz L Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011 [No Abstract] [Full Text] [Related]
10. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease. Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963 [TBL] [Abstract][Full Text] [Related]
11. Failure of aminooxyacetic acid therapy in Huntington disease. Perry TL; Wright JM; Hansen S; Allan BM; Baird PA; MacLeod PM Neurology; 1980 Jul; 30(7 Pt 1):772-5. PubMed ID: 6446691 [TBL] [Abstract][Full Text] [Related]
12. Brain amino compounds in a Huntington's disease patient on isoniazid therapy. Perry TL; Wall RA; Hansen S Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886 [TBL] [Abstract][Full Text] [Related]
14. INH therapy: benefits versus risks. Smith DB Neurology; 1979 Oct; 29(10):1437-8. PubMed ID: 158144 [No Abstract] [Full Text] [Related]
15. [Symptomatic therapy in a possible animal model for Huntington's chorea]. Schneider G; Oepen H; Klapproth A Arzneimittelforschung; 1981; 31(3):437-41. PubMed ID: 6452881 [TBL] [Abstract][Full Text] [Related]
16. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment]. Yamamoto M; Otsuki S; Miyake K; Namba R No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804 [No Abstract] [Full Text] [Related]
17. Efficiency of carbamazepine in the treatment of micturitional disturbances in Huntington disease. Cochen V; Degos JD; Bachoud-Lévi AC Neurology; 2000 Dec; 55(12):1934. PubMed ID: 11134405 [No Abstract] [Full Text] [Related]
18. [Sleep in Huntington chorea: its modification following lithium carbonate and lithium carbonate-haloperidol therapy]. Puca F; Specchio LM; Genco S; Internò S; Castriotta R Riv Neurol; 1978; 48(6):708-16. PubMed ID: 154167 [No Abstract] [Full Text] [Related]
20. [Good effect of valproate against aggression in Huntington disease. Only two cases reported earlier]. Rask G; Andersson C Lakartidningen; 2010 Dec 1-7; 107(48):3060-1. PubMed ID: 21287753 [No Abstract] [Full Text] [Related] [Next] [New Search]